Biotech

All Articles

Kailera launches with $400M set A, 4 Chinese excessive weight medications

.Kailera Therapies has actually launched right into the more and more jampacked being overweight spa...

Metsera partner with Amneal to lock down GLP-1 source

.With early phase 1 data today out in the wild, metabolic ailment ensemble Metsera is actually squan...

Rivus articles records to back up muscle-sparing being overweight medicine claims

.Rivus Pharmaceuticals has introduced the information responsible for its phase 2 excessive weight s...

BMS spends $110M to develop T-cell therapy contract, assisting Excellent purchase opportunity to advance prioritized pipeline

.Bristol Myers Squibb is paying for Excellent Medication $110 thousand beforehand to build reagents ...

Generate increases one more $1B-plus Large Pharma relationship

.Novartis has tattooed an offer potentially worth greater than $1 billion along with Flagship-founde...

Metsera GLP-1 data cut shows 7.5% weight-loss at 36 days

.Lately debuted Metsera is actually unfolding some stage 1 record for its GLP-1 receptor agonist, ex...

Flagship really hopes biotechs group to Mirai to enhance genetic medications

.Amid the genetic medicines branches race, Front runner Pioneering is revealing a brand new business...

BioAge eyes $180M from IPO, private placement for obesity trials

.BioAge Labs is actually looking at about $180 million in first earnings from an IPO and also a priv...

Merck's LAG-3 combination stops working colon cancer cells stage 3 research study

.A try by Merck &amp Co. to uncover the microsatellite dependable (MSS) metastatic colon cancer mark...

Spanish VC shuts $200M lifestyle scientific researches fund

.Spain-based Asabys Allies has closed a fund of 180 million euros ($ 200 thousand), funds that will ...